Toronto Dominion Bank
CRL icon

Toronto Dominion Bank’s Charles River Laboratories CRL Stock Holding History

Toronto Dominion Bank’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.74M Sell
7,681
-39,031
-84% -$6.95M ﹤0.01% 1289
2026
Q1 		$8.06M Buy
46,712
+38,245
+452% +$7.09M 0.01% 693
2025
Q4 		$1.69M Sell
8,467
-12,675
-60% -$2.3M ﹤0.01% 1160
2025
Q3 		$3.31M Buy
21,142
+10,220
+94% +$1.62M 0.01% 908
2025
Q2 		$1.66M Buy
10,922
+753
+7% +$100K ﹤0.01% 1017
2025
Q1 		$1.53M Sell
10,169
-7,167
-41% -$1.2M ﹤0.01% 1002
2024
Q4 		$3.2M Sell
17,336
-8,281
-32% -$1.6M 0.01% 813
2024
Q3 		$5.05M Buy
25,617
+397
+2% +$82.5K 0.01% 612
2024
Q2 		$5.21M Sell
25,220
-3,812
-13% -$864K 0.01% 626
2024
Q1 		$7.87M Buy
29,032
+606
+2% +$145K 0.01% 548
2023
Q4 		$6.72M Buy
28,426
+7,973
+39% +$1.57M 0.01% 652
2023
Q3 		$4.01M Sell
20,453
-2,416
-11% -$496K 0.01% 738
2023
Q2 		$4.8M Sell
22,869
-2,775
-11% -$552K 0.01% 708
2023
Q1 		$5.17M Buy
25,644
+29
+0.1% +$6.57K 0.01% 671
2022
Q4 		$5.58M Buy
25,615
+3,655
+17% +$798K 0.01% 662
2022
Q3 		$4.32M Sell
21,960
-4,078
-16% -$880K 0.01% 707
2022
Q2 		$5.57M Sell
26,038
-3,915
-13% -$957K 0.01% 550
2022
Q1 		$8.51M Buy
29,953
+251
+0.8% +$77.4K 0.01% 497
2021
Q4 		$11.2M Buy
29,702
+2,287
+8% +$889K 0.02% 475
2021
Q3 		$11.3M Buy
27,415
+5,386
+24% +$2.24M 0.02% 421
2021
Q2 		$8.15M Buy
+22,029
New +$7.36M 0.01% 507
2020
Q4 		– Sell
-4
Closed -$1K – 1362
2020
Q3 		$1K Hold
4
– – ﹤0.01% 1176
2020
Q2 		$1K Buy
+4
New +$638 ﹤0.01% 1190
2019
Q4 		– Sell
-26
Closed -$3K – 1380
2019
Q3 		$3K Hold
26
– – ﹤0.01% 1354
2019
Q2 		$4K Buy
+26
New +$3.53K ﹤0.01% 1300
2013
Q3 		– Sell
-1,200
Closed -$49K – 778
2013
Q2 		$49K Buy
+1,200
New +$51.4K ﹤0.01% 649

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Toronto Dominion Bank's CRL Position: Q2 2026 in Review

Toronto Dominion Bank reduced its Charles River Laboratories (CRL) stake by 84% in Q2 2026, selling an estimated $6.95M and leaving 7,681 shares worth $1.74M. The position accounts for ﹤0.01% of the portfolio, ranked #1289.

Toronto Dominion Bank first reported a position in CRL in Q2 2013 and has held it in 26 quarters since. The position peaked at $11.3M in Q3 2021. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Toronto Dominion Bank held 7,681 shares of Charles River Laboratories worth $1.74M as of Q2 2026.
  • Toronto Dominion Bank sold 39,031 Charles River Laboratories shares in Q2 2026, an estimated $6.95M.
  • Charles River Laboratories made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #1289 holding.
  • Toronto Dominion Bank first reported a position in Charles River Laboratories in Q2 2013 and has held it in 26 quarters since.
  • Toronto Dominion Bank's Charles River Laboratories position peaked at $11.3M in Q3 2021.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.